4.6 Article

Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy

期刊

JOURNAL OF IMMUNOLOGY
卷 187, 期 2, 页码 726-732

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1002581

关键词

-

资金

  1. Netherlands Organization for Scientific Research [VENI 916.36.079, VIDI 016.086.320]
  2. Cancer Center Amsterdam/VUmc Institute for Cancer and Immunology

向作者/读者索取更多资源

Neutrophils are the most abundant circulating FcR-expressing WBCs with potent cytotoxic ability. Currently, they are recognized as promising effector cells for Ab-mediated immunotherapy of cancer, because their capacity to kill tumor cells is greatly enhanced by tumor Ag-specific mAbs. The Fc alpha RI represents the most potent FcR on neutrophils for induction of Ab-mediated tumor cell killing. However, the mechanisms of cell death that are induced are poorly understood. Because these mechanisms can be used for modulation of anticancer treatment, we investigated the tumor cell death induced by neutrophil-mediated Ab-dependent killing via Fc alpha RI. Human mammary carcinoma cells were efficiently killed when incubated with human neutrophils and tumor-specific Fc alpha RI bispecific or IgA Abs. Interestingly, we observed characteristics of autophagy such as autophagic structures by electron microscopy and LC3B(+) autophagosomes in different human epithelial carcinoma cells, which resulted in tumor cell death. To a lesser extent, necrotic features, such as cellular membrane breakdown and spillage of intracellular content, were found. By contrast, apoptotic features including fragmented nuclei, Annexin V-positivity, and presence of cleaved caspase-3 were not observed. These findings indicate that neutrophils mainly facilitate autophagy to induce tumor cell death rather than the more commonly recognized apoptotic cell death mechanisms induced by NK cells or cytotoxic T cells. This knowledge not only reveals the type of tumor cell death induced in neutrophil-mediated, Ab-dependent cellular cytotoxicity, but importantly opens up additional perspectives for modulation of anticancer therapy in, for example, apoptosis-resistant tumor cells. The Journal of Immunology, 2011, 187: 726-732.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据